Variations beyond two days should be discussed with your prescriber to avoid unintended gaps in therapy or dose stacking
The observational study looked at over 200,000 mammograms of women between the ages of 45 and 80 to assess breast cancer detection
Stop taking it at least two weeks before any scheduled procedure
Pooled analysis reported no significant effect on not only total arrhythmia [RR=0.96, 95% CI (0.96, 1.05), p =0.36] ( Figure 2 ), but also its subtypes atrial fibrillation [RR=0.96, 95% CI (0.86, 1.07), p =0.43] ( Figure 3 ), atrial flutter [RR= 0.82, 95% CI (0.57, 1.19), p =0.30] ( Figure 3 ), atrial tachycardia [RR=0.64, 95% CI (0.20, 2.01), p =0.44)] ( Figure 3 ), sinoatrial node dysfunction [RR=0.74, 95% CI (0.44, 1.25), p =0.26] ( Figure 3 ), ventricular preterm systole [RR=1.42, 95% CI (0.62, 3.26), p =0.41] ( Figure 3 ), second degree AV block [RR=0.96, 95% CI (0.53, 1.72), p =0.88] ( Figure 3 ), complete AV block [RR=0.75, 95% CI (0.49, 1.17), p =0.21] ( Figure 3 ), ventricular fibrillation [RR=1.00, 95% CI (0.50, 2.02), p =1.00] ( Figure 3 ), ventricular tachycardia [RR=1.37, 95% CI (0.91, 2.08), p =0.13] ( Figure 3 ) from treatment with GLP-1RA versus placebo
The study found that those who started on GLP-1-RAs had a lower risk of all-cause mortality and major cardiovascular events, such as heart attacks and strokes, compared to those who started on DPP-4is
